Trials / Conditions / Peripheral T-cell Lymphomas
Peripheral T-cell Lymphomas
5 registered clinical trials studyying Peripheral T-cell Lymphomas — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma NCT03922724 | National Cancer Institute (NCI) | Phase 2 |
| Unknown | Endostar Aggressive Treatment of Peripheral T-cell Lymphoma (PTCL) Phase II Clinical Study NCT02520219 | Nanjing NingQi Medicine Science and Technology Co., Ltd. | Phase 2 |
| Terminated | Lenalidomide Therapy for Patients With Relapsed and/or Refractory, Peripheral T-Cell Lymphomas NCT00704691 | University of Alabama at Birmingham | EARLY_Phase 1 |
| Completed | Alemtuzumab and CHOP Chemotherapy for Aggressive Histological Peripheral T-Cell Lymphomas NCT00453427 | Ontario Clinical Oncology Group (OCOG) | Phase 1 / Phase 2 |
| Completed | Bortezomib and CHOP in Patients With Advanced Stage Aggressive T Cell or Natural Killer (NK)/T Cell Lymphomas NCT00374699 | Samsung Medical Center | Phase 1 / Phase 2 |